Download references
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy
-
* Corresponding author: Duncan Wyncoll duncan.wyncoll@gstt.nhs.uk
Critical Care 2008, 12:R163 doi:10.1186/cc7163